Please login to the form below
Illumina
This page shows the latest Illumina news and features for those working in and with pharma, biotech and healthcare.
Genentech pays $30m upfront to access Bicycle Therapeutic's discovery technology
That includes a recent alliance with Illumina on genomic testing for cancer diagnostics, which aims to define a patient’s unique cancer using the genomics systems and leverage the resulting genomic
Latest news
-
Roche and Illumina partner on genomics for cancer diagnostics
Will leverage genomics system to match optimal cancer treatment. Roche and Illumina have announced a 15-year alliance for genomics testing, aimed at transforming cancer diagnostics. . ... Roche will collaborate with Illumina to complement its
-
UK government raises concerns about Illumina’s $1.2bn takeover of PacBio
One of these includes Genomics England, with Illumina providing the genome sequencing systems for the 100, 000 Genome Project. ... Illumina announced its plans to acquire PacBio in No. vember last year, for $1.2bn in an all-cash transaction.
-
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region. Illumina has set up its first hub for genomics start-up funding outside the US, and has chosen Cambridge in the UK for ... harness the rapid and affordable next-generation sequencing technology pioneered by
-
Grail’s multi-cancer blood test gets FDA breakthrough status
Grail is a spin-out of genome sequencing giant Illumina, and is leveraging the whole genome sequencing (WGS) power of its parent company with the goal of revolutionising cancer diagnostics.
-
Loxo, Bayer get FDA okay for biomarker-driven cancer drug
To try to address the diagnostic issue, Loxo formed a partnership earlier this year with Illumina to develop a simple test – called TruSight Tumour 170 – that will use sequencing to identify
More from news
Approximately 10 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare
centre run by Illumina, and an automated analytics platform to return whole genome analyses to the NHS.
-
Deal Watch January 2017
IBM Watson Health/ Illumina. Partnership to integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumour sequencing process to expand access to genomic data.
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Pharma deals during July 2013
Roche, rumoured to be interested in Alexion, may still be smarting from the battle to try and take over Illumina last year.
-
What can pharma learn from Olympic sports coverage?
So where could Roche go next? With its unsuccessful takeover bid for Illumina, it could be a move into genetic sequencing to augment their oncology capability and more besides.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Illumina expands board of directors
John Thompson brings experience from IBM and Microsoft. San Diego, US-based Illumina has appointed John Thompson to its board of directors. ... Francis de Souza, president and chief executive of Illumina, said: “John brings a great breadth of knowledge
-
GlobalData makes Americas appointment
He has spent 18 years in varous positions in the life sciences consulting industry, including roles at, Bionest Partners, IMS Management Consulting, and Illumina Inc.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Dan Coffin joins London Headquarters as Director
Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
-
Why is the UK lagging behind the rest of Europe in cancer survival?
To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “ stethoscope for the next 200 years.” A
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- AZ strengthens Daiichi Sankyo partnership with new ADC deal
- Gut instincts lead Takeda to GI pipeline success
- AbbVie, Amgen and Takeda team up for joint COVID-19 trial
- How will the events and exhibitions industry change post-Coronavirus?
- AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- Porterhouse Medical Group joins imc group
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Bristol-Myers Squibb’s revenues rise on Celgene acquisition
- Socially distanced strategising
- Artificial Intelligence in Digital Therapeutics
PMHub
Healthcircle
We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
